Guidance Recipients
Match would-be startups with local industry, academia, and related institutionsMolecular Diagnostic Kit for Endometrial Cancer
Lai Hung-cheng, Taipei Medical University Hospital
Year 2017Year
Period:2017-12-01 to 2019-05-31
Overview
- Endometrial cancer is one of the most common female cancers. Diagnosis relies heavily on either invasive tests that often fail or medical imaging that does not always promise accuracy.
- DNA methylation is adopted as a biomarker for endometrial cancer diagnosis, making possible an easy-to-perform procedure and sparing the need for invasive tests.
- Offer an effective approach to the diagnosis of endometrial cancer and promote the health of women.
Development Process
Over the course of this project under the Applied Research Incubation Program, the team established product definition and specifications, spelled out product applications and indications, conducted clinical trials at three hospitals, and wrote a startup business plan. Since the establishment of Guzip Biomarkers Corp. on August 7, 2018, BMCC has continued to offer assistance in product commercialization.
